PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US)

NCT02747823 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cipla BioTec Pvt. Ltd.

Collaborators